Related references
Note: Only part of the references are listed.Nitrosative stress in Parkinson's disease
Morgan G. Stykel et al.
NPJ PARKINSONS DISEASE (2022)
Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease
Yunna Li et al.
FRONTIERS IN IMMUNOLOGY (2021)
Systemic activation of Nrf2 pathway in Parkinson's disease
Sara Petrillo et al.
MOVEMENT DISORDERS (2020)
Apelin-36 mediates neuroprotective effects by regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson's disease model mice
Junge Zhu et al.
BRAIN RESEARCH (2020)
Lactulose and Melibiose Inhibit α-Synuclein Aggregation and Up-Regulate Autophagy to Reduce Neuronal Vulnerability
Chiung Mei Chen et al.
CELLS (2020)
The Role of Oxidative Stress in Parkinson's Disease
Kuo-Hsuan Chang et al.
ANTIOXIDANTS (2020)
MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration
Eunju Lee et al.
CELL DEATH AND DIFFERENTIATION (2019)
FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation
Shu Yao et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2019)
Microglia-mediated neuroinflammation in neurodegenerative diseases
Charannya Sozheesvari Subhramanyam et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Neuroprotection of Indole-Derivative Compound NC001-8 by the Regulation of the NRF2 Pathway in Parkinson's Disease Cell Models
Pei-Cih Wei et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Indole Compound NC009-1 Augments APOE and TRKA in Alzheimer's Disease Cell and Mouse Models for Neuroprotection and Cognitive Improvement
Yi-Chun Chen et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Lipophilic antioxidants in neurodegenerative diseases
Kuo-Hsuan Chang et al.
CLINICA CHIMICA ACTA (2018)
The indole compound NC009-1 inhibits aggregation and promotes neurite outgrowth through enhancement of HSPB1 in SCA17 cells and ameliorates the behavioral deficits in SCA17 mice
Chiung-Mei Chen et al.
NEUROTOXICOLOGY (2018)
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
Richard Gordon et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The Potential of Indole/Indolylquinoline Compounds in Tau Misfolding Reduction by Enhancement of HSPB1
Kuo-Hsuan Chang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2017)
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier et al.
NATURE REVIEWS NEUROSCIENCE (2017)
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2
Michela Campolo et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production
Victor Tapias et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
Isabel Lastres-Becker et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
Caroline H. Williams-Gray et al.
MOVEMENT DISORDERS (2016)
Cdk5-Dependent Activation of Neuronal Inflammasomes in Parkinson's Disease
Pei Zhang et al.
MOVEMENT DISORDERS (2016)
Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson's disease
Kuo-Hsuan Chang et al.
PARKINSONISM & RELATED DISORDERS (2016)
Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs
Taysa Bervian Bassani et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2015)
[11C]PBR28 PET imaging is sensitive to neuroinflammation in the aged rat
Matthew D. Walker et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
Erdinc Dursun et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Systemic inflammation and microglial activation: systematic review of animal experiments
Inge C. M. Hoogland et al.
JOURNAL OF NEUROINFLAMMATION (2015)
AlzPlatform: An Alzheimer's Disease Domain-Specific Chemogenornics Knowledgebase for Polypharmacology and Target Identification Research
Haibin Liu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Correlation between Serum RANTES Levels and the Severity of Parkinson's Disease
Peng Tang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Animal models of Parkinson's disease
Fabio Blandini et al.
FEBS JOURNAL (2012)
Correlation between Protective Immunity to α-Synuclein Aggregates, Oxidative Stress and Inflammation
Marina A. Gruden et al.
NEUROIMMUNOMODULATION (2012)
Quercetin and Sesamin Protect Dopaminergic Cells from MPP+-Induced Neuroinflammation in a Microglial (N9)-Neuronal (PC12) Coculture System
Julie Bournival et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Non-Motor Symptoms in Patients with Parkinson's Disease - Correlations with Inflammatory Cytokines in Serum
Daniel Lindqvist et al.
PLOS ONE (2012)
Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease
Lauren Broom et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease
D. Allan Butterfield et al.
FREE RADICAL RESEARCH (2011)
MPTP-Induced Neuroinflammation Increases the Expression of Pro-Inflammatory Cytokines and Their Receptors in Mouse Brain
Dario Domenico Lofrumento et al.
NEUROIMMUNOMODULATION (2011)
Neurodegeneration and Inflammation in Parkinson's disease
Sudarshan Phani et al.
PARKINSONISM & RELATED DISORDERS (2011)
Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease
Dawn Béraud et al.
PARKINSONISM & RELATED DISORDERS (2011)
Genetic Ablation of PLA2G6 in Mice Leads to Cerebellar Atrophy Characterized by Purkinje Cell Loss and Glial Cell Activation
Zhengshan Zhao et al.
PLOS ONE (2011)
Short communication Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease
T. Müller et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Neuroprotective Effect of Gypenosides against Oxidative Injury in the Substantia Nigra of a Mouse Model of Parkinson's Disease
P. Wang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
K. Ray Chaudhuri et al.
LANCET NEUROLOGY (2009)
Interleukin-6 Serum Levels in Patients with Parkinson's Disease
Kerly Wollmeister Hofmann et al.
NEUROCHEMICAL RESEARCH (2009)
Novel synthesis of indolylquinoline derivatives via the C-alkylation of Baylis-Hillman adducts
Chintakunta Ramesh et al.
TETRAHEDRON LETTERS (2009)
Health effects of quercetin: From antioxidant to nutraceutical
Agnes W. Boots et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
Bogdan Brodacki et al.
NEUROSCIENCE LETTERS (2008)
Nrf2--mediated protection against 6-hydroxydopamine
Rebekah J. Jakel et al.
BRAIN RESEARCH (2007)
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Liya Qin et al.
GLIA (2007)
Abnormal levels of prohibitin and ATP synthase in the substantia nigira and frontal cortex in Parkinson's disease
I. Ferrer et al.
NEUROSCIENCE LETTERS (2007)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Parkinsonism: A review-of-systems approach to diagnosis
Paul J. Tuite et al.
SEMINARS IN NEUROLOGY (2007)
Structure-brain exposure relationships
Stephen A. Hitchcock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1β in the substantia nigra
Carina Cintia Ferrari et al.
NEUROBIOLOGY OF DISEASE (2006)
Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests
D Dhingra et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
Genetic ablation of tumor necrosis factor-alpha (TNF-α) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum
B Ferger et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Pathogenic role of glial cells in Parkinson's disease
P Teismann et al.
MOVEMENT DISORDERS (2003)
Oxidative stress in Parkinson's disease
P Jenner
ANNALS OF NEUROLOGY (2003)
MPP plus analogs acting on mitochondria and inducing neuro-degeneration
Y Kotake et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease
K Sriram et al.
FASEB JOURNAL (2002)
Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe
BX Ou et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2001)
Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo
T Dehmer et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
